PATTISON Outdoor Open to Applications for 2024’s Elevating Voices Grant
February 15, 2024 06:00 ET
|
PATTISON Outdoor Advertising LP
Pictured above: Royal Bank Plaza Digital Wall, featuring an advertisement for The Forum, an Elevating Voices Grant recipient MISSISSAUGA, Ontario, Feb. 15, 2024 (GLOBE...
Vandria Awarded €3.8M in Prestigious Innosuisse and Eurostars Grants to Advance Innovative Drug Programs for Age-Related Diseases of the CNS and Muscle
February 08, 2024 03:00 ET
|
Vandria
Vandria is advancing a portfolio of mitophagy inducers to address age-related chronic diseases of the CNS, muscle, lung and liverInnosuisse grant totalling CHF 2.5M (€2.7M) to support early clinical...
Yamaha Empowers E-Bike Communities with Groundbreaking Outdoor Access Initiative Grants
January 18, 2024 15:00 ET
|
Yamaha Motor Corp., USA
MARIETTA, Ga., Jan. 18, 2024 (GLOBE NEWSWIRE) -- Yamaha Motor Corp., USA, proudly announces a groundbreaking chapter in outdoor access with the Yamaha Outdoor Access Initiative (OAI) awarding two...
Water Mission Awarded $1 Million Grant from The Coca-Cola Foundation, Funding Safe Water Programming in Uganda and Tanzania
January 18, 2024 08:59 ET
|
Water Mission
Water Mission, is partnering with The Coca-Cola Foundation on a safe water program grant that will benefit more than 53,000 people in Uganda and Tanzania.
La FDA Américaine Accorde la Qualification de Médicament Orphelin au PTX-252 pour le Traitement de la Leucémie Myéloïde Aiguë (LMA)
January 16, 2024 13:30 ET
|
Hyloris Pharmaceuticals SA
La FDA Américaine Accorde la Qualification de Médicament Orphelin au PTX-252 pour le Traitement de la Leucémie Myéloïde Aiguë (LMA) Le PTX-252 (précédemment appelé agent plécoïdeTM) est une nouvelle...
Orphan Drug Designation Granted to PTX-252 by U.S. FDA for the Treatment of Acute Myeloid Leukaemia (AML)
January 16, 2024 13:30 ET
|
Hyloris Pharmaceuticals SA
Orphan Drug Designation Granted to PTX-252 by U.S. FDA for the Treatment of Acute Myeloid Leukaemia (AML) PTX-252 (previously referenced as a Plecoid™Agent) is a novel molecular entity developed in...
ARC Opens Applications for 2024 Substance Use Disorder Recovery-to-Work Projects
January 08, 2024 14:00 ET
|
Appalachian Regional Commission
Washington, DC, Jan. 08, 2024 (GLOBE NEWSWIRE) -- WASHINGTON, D.C., January 8, 2024—The Appalachian Regional Commission (ARC) issued a Notice of Solicitation of Applications for its Investments...
Operation Come Home provides a welcoming and warm place for youth, thanks to an Ontario Trillium Foundation grant
December 20, 2023 08:26 ET
|
Operation Come Home
Operation Come Home provides a welcoming and warm place for youth, thanks to an Ontario Trillium Foundation grant
Novacium reçoit une subvention de 90 000 € pour ces travaux sur les matériaux SiOx spécifiquement conçus pour les anodes de batteries
December 20, 2023 07:30 ET
|
Ressources HPQ Silicium inc.
MONTRÉAL, 20 déc. 2023 (GLOBE NEWSWIRE) -- HPQ Silicium inc. (« HPQ » ou « la Société ») (TSX-V: HPQ) (OTCQB: HPQFF) (FRA: O08), une entreprise technologique spécialisée dans l'ingénierie...
Novacium Awarded € 90,000 Grant Towards Work on Its Engineered SiOx Anode Battery Material
December 20, 2023 07:30 ET
|
HPQ Silicon Inc.
MONTREAL, Dec. 20, 2023 (GLOBE NEWSWIRE) -- HPQ Silicon Inc. (“HPQ” or the “Company”) (TSX-V: HPQ) (OTCQB: HPQFF) (FRA: O08), a technology company specializing in green engineering of silica and...